body mass index;
end-stage renal disease;
glomerular filtration rate;
high cardiovascular risk;
mortality;
obesity;
OBESITY;
DISEASE;
OVERWEIGHT;
UNDERWEIGHT;
OUTCOMES;
PARADOX;
CKD;
D O I:
10.1111/nep.13970
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
Background There is increasing awareness of the impact of obesity and underweight on cardiovascular (CV) disease, chronic kidney disease (CKD) and mortality. Abnormal body mass index (BMI) might be associated with worse clinical outcomes, including CKD progression, but limited evidence exists among Asian patients with high CV risk. Objective To investigate the association of BMI with progressive loss of kidney function and all-cause mortality in Thai patients with high CV risk. Methods In a national cohort of 5887 high CV risk subjects, we assessed the association of high BMI with the composite renal outcome (estimated glomerular filtration rate [eGFR] decline over 40%, eGFR less than 15 mL/min/1.73 m(2), doubling of serum creatinine, initiation of dialysis and death related to renal causes) and with all-cause mortality in Cox proportional hazards models. Results A total of 5887 participants (3217 male and 2670 female) with high CV risk were enrolled. Participants were classified into five groups by their baseline BMI; <20 kg/m(2) (n = 482), 20-24.9 kg/m(2) (n = 2437), 25-29.9 kg/m(2) (n = 2140), 30-34.9 kg/m(2) (n = 665) and 35 kg/m(2) (n = 163), respectively. On multivariate analysis of Cox proportional hazards models, adjusted for other covariates, baseline BMI >= 35 kg/m(2) was an independent predictor of loss of kidney function (HR 1.60, 95% CI 1.04-2.40) and all-cause mortality (HR 2.68, 95% CI 1.50-4.80). Baseline BMI <20 kg/m(2) was an independent predictor of all-cause mortality as well (adjusted HR 2.26, 95% CI 1.50-3.42). Conclusion In the high CV risk Thai population, a BMI of 35 kg/m(2) or more is associated with loss of kidney function and mortality. On the other hand, a BMI less than 20 kg/m(2) is also associated with all-cause mortality.
机构:
Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Internal Med, Incheon, South Korea
Catholic Kwandong Univ, Coll Med, Inst Biomed Convergence, Kangnung, Gangwon Do, South KoreaCatholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Internal Med, Incheon, South Korea
机构:
Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea
Cho, Yun Kyung
论文数: 引用数:
h-index:
机构:
Kim, Ye-Jee
Jung, Chang Hee
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea
Asan Med Ctr, Asan Diabet Ctr, Seoul, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea
Jung, Chang Hee
论文数: 引用数:
h-index:
机构:
Lee, Woo Je
Park, Joong-Yeol
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea
Asan Med Ctr, Asan Diabet Ctr, Seoul, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea
Park, Joong-Yeol
Huh, Ji Hye
论文数: 0引用数: 0
h-index: 0
机构:
Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea
Huh, Ji Hye
Kang, Jun Goo
论文数: 0引用数: 0
h-index: 0
机构:
Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea
Kang, Jun Goo
Lee, Seong Jin
论文数: 0引用数: 0
h-index: 0
机构:
Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea
Lee, Seong Jin
Ihm, Sung-Hee
论文数: 0引用数: 0
h-index: 0
机构:
Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South KoreaHallym Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Chunchon, South Korea